Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein
A. Lundgren, S. Leach, J. Tobias, N. Carlin, B. Gustafsson, M. Jertborn, L. Bourgeois, R. Walker, J. Holmgren, A. M. Svennerholm
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein'. Together they form a unique fingerprint.